What is the appropriate dosing regimen for citalopram (Celexa) in adults, including adjustments for elderly patients and those with hepatic impairment?

Citalopram (Celexa) Dosing

Start citalopram at 20 mg once daily in most adults, with a maximum dose of 40 mg/day; elderly patients (≥60 years) and those with hepatic impairment should start at 20 mg/day and remain at this dose, as higher doses provide no additional benefit but increase cardiac risk. 1

Standard Adult Dosing (Ages 18-59)

• Initial dose: 20 mg once daily (morning or evening, with or without food)
• Titration: Increase to 40 mg/day after at least 1 week if needed
• Maximum dose: 40 mg/day 1
• Important: Doses above 40 mg are not recommended—the pivotal efficacy trial showed no advantage of 60 mg/day over 40 mg/day 1

The FDA drug label is explicit here: while some patients historically received 60 mg/day, clinical evidence does not support exceeding 40 mg daily in standard adults 1. This recommendation is reinforced by guideline evidence showing citalopram at 10 mg/day is well-tolerated with a maximum of 40 mg/day 2.

Elderly Patients (≥60 Years)

Elderly patients should receive 20 mg/day as both the starting and maximum dose 1. This is critical because:

• Citalopram AUC increases 23-30% and half-life increases 30-50% in elderly patients 1, 3
• The 2011 FDA safety communication specifically capped elderly dosing at 20 mg/day due to QT prolongation concerns 1
• Pharmacokinetic studies demonstrate significantly prolonged drug exposure in patients ≥60 years 3

While some debate exists about the clinical significance of QT prolongation 4, 5, the FDA restriction remains in effect and should guide prescribing 1.

Hepatic Impairment

Patients with hepatic impairment should receive 20 mg/day as the maximum dose 1. The rationale:

• Oral clearance decreases by 37% and half-life doubles in hepatically impaired patients 1, 6
• Volume of distribution increases significantly 6
• Titration to 40 mg/day should only occur in non-responders, and only with careful monitoring 1

Renal Impairment

• Mild to moderate renal impairment: No dose adjustment needed 1
• Severe renal impairment (CrCl <20 mL/min): Use with caution; no specific dosing data available 1, 6
• Renal clearance accounts for only ~20% of total citalopram elimination 1

Maintenance Treatment

• Continue treatment for 6-8 months minimum after achieving remission from a first depressive episode 7
• For recurrent depression, consider longer-term or indefinite treatment 7
• The dose that achieved remission should generally be maintained 1
• If adverse effects are bothersome during maintenance, reduction to 20 mg/day can be considered 1

Discontinuation

Taper gradually rather than stopping abruptly to minimize withdrawal symptoms 1. If intolerable symptoms occur:

1. Resume the previous dose
2. Then decrease more slowly over time
3. Consider reducing by 10 mg every 1-2 weeks

Drug Interactions

Citalopram is metabolized primarily by CYP3A4 and CYP2C19 1. However:

• Ketoconazole (potent CYP3A4 inhibitor) did not significantly affect citalopram pharmacokinetics 1
• CYP2D6 poor metabolizers show no significant difference in steady-state levels 1
• Multiple enzyme pathways provide redundancy, making single-enzyme inhibition less clinically significant 1

MAOI Interactions

Allow at least 14 days between discontinuing an MAOI and starting citalopram, and vice versa 1. This washout period is mandatory to prevent serotonin syndrome.

Common Pitfalls

1. Exceeding 40 mg/day in standard adults: No evidence of additional benefit, increased cardiac risk
2. Using >20 mg/day in elderly patients: FDA-restricted due to QT prolongation
3. Abrupt discontinuation: Always taper to minimize withdrawal symptoms
4. Ignoring hepatic impairment: Requires dose reduction to 20 mg/day maximum
5. Assuming all SSRIs dose similarly: Citalopram has specific restrictions not applicable to other SSRIs like sertraline 2, 7